MAKLUMAT INDUSTRI DAN SAINS INFORMATION SERVICE FOR COMMERCE & INDUSTRY
PENANG ON BIOTECH DRIVE Penang, often referred to as the "Silicon Island of the East", is embarking on a biotechnology drive in a bid to attract investment and research activities. The move attempts to leverage on the biotechnology demand which is projected to spin an industry worth U...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Perpustakaan Universiti Sains Malaysia
2004
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/33813/1/Midas_jan-_mac_04.pdf http://eprints.usm.my/33813/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | PENANG ON BIOTECH DRIVE
Penang, often referred to as the "Silicon Island of the East",
is embarking on a biotechnology drive in a bid to attract
investment and research activities. The move attempts to
leverage on the biotechnology demand which is projected
to spin an industry worth US$1.76 trillion (RM6.7 trillion)
by 2010, sources were quoted. The 176-hectare plot of land
at the Bukit Minyak Industrial Park has already attracted
three biotechnology projects with a total investment
estimated at US$70 million. The biggest of these is Londonlisted
firm GeneMedix Plc, which last year signed a letter of
intent with the Penang Development Corporation (PDC) to
produce human insulin to meet the expected rise in demand
from diabetes patients across Asia. The investment is US$35
million. The two other projects are a US$20 million contract
manufacturing plant to produce compounds used in
cancer-fighting drugs and a US$15 million contract research
firm specialising in pre-clinical trials. |
|---|